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Abstract Resistance to the neomycin analogue G418 forms the 
basis of a dominant marker selection system for mammalian cells 
transfected with the bacterial neomycin gene. We found that 
COS-1 cells stably transfected with the neomycin resistance gene 
had a greater than 50% reduction in cell-associated glycosyl-
phosphatidylinositol (GPI)-anchored alkaline phosphatase (AP). 
A similarly reduced amount of AP was also observed in wild-type 
COS-1 cells incubated in the presence of G418 or other 
aminoglycoside antibiotics. The AP was released from cells into 
the culture supernatant in its GPI-anchored form. Our data 
suggest that the G418-induced reduction of AP involves a 
vesiculation process of COS-1 cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Chemical modification of foreign molecules represents one 
of several mechanisms used by bacteria to evade toxic com-
pounds and forms the basis of bacterial resistance to amino-
glycoside antibiotics [1]. These compounds have been pro-
posed to act (in part) by binding to the bacterial 30S 
ribosomal subunit and initiate a complex series of events lead-
ing to cell death [2]. The resistance of bacteria to aminoglyco-
side antibiotics is mainly the result of production of detoxify-
ing enzymes that fall into three classes named according to the 
site which they modify on the antibiotic, the O-phosphotrans-
ferases, the O-adenylyltransferases, and the N-acetyltransfer-
ases [3]. The resulting enzymatically modified aminoglycosides 
lack the toxic properties since they no longer bind with high 
affinity to ribosomes. 
The aminoglycoside G418 is often used in conjunction with 
eukaryotic expression vectors encoding genes whose products 
inactivate G418. Resistance to G418 and other aminoglyco-
side antibiotics forms the basis of dominant marker selection 
systems of mammalian (and other) cells transfected with the 
bacterial neomycin (neo) gene. This system has been particu-
larly effective because of the low incidence of spontaneous 
conversion to G418 resistance in mammalian cells [4]. The 
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mechanism by which G418 exerts its slow toxicity in eukar-
yotes is thought to involve inhibition of protein synthesis by 
binding to 80S ribosomes [5]. In addition, some aminoglyco-
sides have been reported to interact with various cellular 
components, including negatively charged membrane phos-
pholipids [6], inositolphospholipids [7-9], and inositolphos-
pholipid-cleaving phospholipases C [10,11]. 
In the present study, we report on our recent observation 
that COS-1 cells stably transfected with the neomycin resist-
ance gene as well as wild-type COS-1 cells incubated in the 
presence of the aminoglycoside antibiotic, G418, showed re-
duced amounts of cell-associated alkaline phosphatase (AP) 
activity. Our results suggest that the A P was released from 
COS-1 cells into the culture supernatant by G418-induced 
vesiculation. 
2. Materials and methods 
2.1. Materials 
Unless otherwise stated all reagents were of analytical grade and 
either from Boehringer (Mannheim, Germany), Fluka (Buchs, Swit-
zerland), Sigma (St. Louis, MO), or Merck (Darmstadt, Germany). 
Eagle's minimal essential medium (MEM), L-glutamine, penicillin/ 
streptavidin, geneticin (G418), neomycin, kanamycin, gentamycin, 
and streptomycin were purchased from Gibco BRL (Life Technolo-
gies, Basel, Switzerland). Fetal calf serum (FCS) was from Seback 
GmbH (Aidenbach, Germany) and BACTO trypsin from DIFCO 
Laboratories (Detroit, MI). Acrylamide stock solution was from Na-
tional Diagnostics (Hull, UK). Phosphatidylinositol-specific phospho-
lipase C (PI-PLC) from Bacillus cereus (600 U/mg) was from Boeh-
ringer. 
[3H]Myristate-labeled variant surface glycoprotein (VSG) from 
bloodstream form trypanosomes was prepared following the proce-
dure of Hereld et al. [12], exactly as described before [13]. The mem-
brane-form of acetylcholinesterase (AChE) was purified from bovine 
erythrocytes as described by Brodbeck et al. [14]. Concentrated eryth-
rocytes in standard anticoagulant buffer were obtained from the ZLB 
Central Laboratory, Swiss Red Cross Blood Transfusion Service 
(Bern, Switzerland). 
2.2. Cell cultures 
COS-1 cells were kindly provided by Dr. E. Sterchi, University of 
Bern. Cells were maintained in MEM containing 9% (v/v) FCS (heat 
inactivated for 30 min at 56°C) supplemented with 2 raM L-glutamine, 
100 U/ml penicillin, and 100 ug/ml streptomycin (culture medium). 
Confluent cells were trypsinized, diluted 1:10 in fresh culture medium 
and seeded onto new cell culture dishes. Cells were harvested by 
scraping into 12 ml of ice-cold 0.9% (w/v) NaCl in water, pelleted 
by brief centrifugation (5 min, 250 X g), washed once and resuspended 
in 200 ul of buffer (50 mM Mes, pH 6.5) by sonication for 10 s at 50 
W. 
2.3. Stable transformation of COS-1 cells 
To obtain G418-resistant cell lines, wild-type COS-1 cells were 
transfected with 1 u.g of the vector pXTl carrying the selectable neo-
mycin resistance gene (Stratagene Cloning System, La Jolla, CA), 
using the calcium phosphate method [15]. G418-resistant clones 
were grown in culture medium supplemented with 300 ug/ml of the 
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aminoglycoside antibiotic G418. The obtained resistant clones were 
designated neo-cells. 
2.4. Enzyme activity assays 
2.4.1. Alkaline phosphatase. Prior to assaying AP activity, COS-1 
cells were grown for at least one passage in MEM containing AP-
inactivated FCS [16]. Aliquots of sonicated cells (20 ul) or culture 
supernatants (50 ill) were added to 150 ul of assay solution containing 
1.33 mM diethanolamine (pH 9.8), 0.66 mM MgCl2, and 13.33 mMp-
nitrophenylphosphate, and assayed in a final volume of 200 [il. Con-
version of p-nitrophenylphosphate to p-nitrophenol was measured 
spectrophotometrically at 405 nm over a period of 5-10 min at 
room temperature. In some experiments, AP activity in the cell culture 
supernatants was measured also after high-speed centrifugation (90 
min, 90 000 X g). 
2.4.2. Lactate dehydrogenase (LDH). LDH activity in wild-type 
COS-1 cells and neo-cells was determined exactly as described [17]. 
2.4.3. Na+IK+-ATPase. Na+/K+-ATPase activity in wild-type 
COS-1 cells and neo-cells was measured according to Chignell and 
Titus [18] and calculated as the difference between Pi produced in 
the presence and absence of ouabain. 
2.5. PI-PLC treatment of endogenous AP 
Membrane attachment of endogenous AP via glycosylphosphatidyl-
inositol (GPI) in wild-type COS-1 cells and «eo-cells was analyzed by 
its sensitivity towards B. cereus PI-PLC. Sonicated cell lysates (20 u.1) 
were added to a cocktail containing 20 mM Tris-HCl (pH 7.4), 10 
mM MgCl2 (to maintain AP activity), 0.5% (w/v) Triton X-100, and 
0.03 U PI-PLC. The reaction mixture (50-80 ul final volume) was 
incubated for 3^1 h at 37°C and the enzymatic reaction was stopped 
by addition of 400 ul 4% (w/v) Triton X-114. Control samples con-
tained no PI-PLC. PI-PLC-mediated hydrolysis of the GPI anchor of 
AP was assayed by measuring the distribution of AP activity between 
aqueous and detergent phase after phase partitioning at 37°C [19]. 
GPI anchoring of the AP present in the cell culture supernatant was 
analyzed under identical conditions using 50 ul of culture supernatant. 
2.6. Assay for GPI-hydrolyzing activity in COS-1 cells 
Aliquots (20 ul) of sonicated cell pellets of wild-type COS-1 cells 
and «eo-cells grown in the absence or presence of 750 ug/ml G418 
were assayed for endogenous GPI-hydrolyzing activity using purified 
AChE (400 U/ml) or [3H]myristate-labeled VSG (4000-5000 cpm) as 
substrates, exactly as described before [16]. 
2.7. Treatment of human erythrocytes with G418 and other 
aminoglycoside antibiotics 
Human erythrocytes (2 ml) were pelleted by centrifugation, washed 
three times with 0.9% (w/v) NaCl, and resuspended in 5 ml of incu-
bation buffer (10 mM Tris-HCl (pH 7.4), 144 mM NaCl, 12.7 mM 
inosine, 0.54 mM adenine, 2 g/1 glucose) supplemented with from 750 
ug/ml to 7.5 mg/ml of aminoglycoside antibiotic. After incubation of 
the cells at 37°C under constant gentle shaking, aliquots were re-
moved and erythrocytes were pelleted by centrifugation (30 s, 6000 
rpm) in a microcentrifuge. Total AChE activity in the suspension and 
in the vesicle-containing supernatant after pelleting the red blood cells 
was determined following the procedure of Ellmann et al. [20], as 
described before [21]. Erythrocyte-derived vesicles in the supernatant 
were pelleted by a subsequent centrifugation step (15 min, 13000 rpm) 
in a microcentrifuge. Erythrocyte morphology was examined by light 
microscopy of cells fixed in 3% (v/v) glutaraldehyde. Erythrocyte 
ghosts were prepared from washed cells by hypotonie lysis in 10 
mM Tris-HCl (pH 7.4), containing 2 mM EDTA. 
2.8. Protein analysis 
Protein was determined using the BCA reagent kit (Pierce Chem-
icals, Rockford, IL) with bovine serum albumin as standard. Eryth-
rocyte ghosts and vesicles were analyzed by SDS-polyacrylamide gel 
electrophoresis under reducing conditions using 5-15% polyacryl-
amide gradient gels [22]. 
3. Results and discussion 
Unless otherwise stated, cells were grown in culture medium 
containing AP-inactivated serum for at least one passage be-
fore experiments were started. 
3.1. AP in stably transfected cells 
In previous studies involving stably transfected COS-1 cells 
we observed that , independent of the expressed foreign pro-
tein, the amounts of endogenous A P were decreased com-
pared to wild type, i.e. non-transfected, cells (results not 
shown). Since these cell lines all carried the neomycin resist-
ance gene and were cultured in the presence of the amino-
glycoside antibiotic G418, we hypothesized that the reduction 
in cell-associated A P in stably transfected COS-1 cells is a 
result of the product of the resistance gene and/or the presence 
of G418 in the culture medium. To study this question we 
stably transfected COS-1 cells with the vector p X T l carrying 
the selectable neomycin resistance gene to generate a cell line 
(designated weo-cells) that is resistant to G418 but otherwise 
does not express any other foreign protein. When we analyzed 
these neo-cells grown in the presence of 300 (J,g/ml G418, we 
found that the amount of cell-associated A P was reduced to 
50-60% of control wild-type COS-1 cells. A direct inhibitory 
effect of G418 on the activity of A P could be excluded since 
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Fig. 1. Effects of G418 addition on AP activity in COS-1 cell cul-
tures. A: Wild-type COS-1 cells (open bars) and «eo-cells (solid 
bars) were grown to confluence in 6 cm culture dishes. Subse-
quently, the culture supernatants were replaced by fresh medium 
and the cells were cultured for 24 h in the absence (bars a,c) or 
presence of 750 üg/ml G418 (bars b,d). The specific activity of AP 
in washed cell pellets (bars a-d) is expressed as mean values of trip-
licate determinations ± SD from two separate experiments. The AP 
activity in the culture supernatants of wild-type COS-1 cells cultured 
in the absence (bar e) or presence (bar f) of 750 (tg/ml G418 are ex-
pressed as mean values of triplicate determinations ± SD from a typ-
ical experiment. B: Confluent wild-type COS-1 cells were cultured 
for 56 h in the absence (open circles) or presence of 750 ug/ml 
G418 (closed circles) and the specific activity of AP in the washed 
cell pellets was measured at the indicated time points. The values 
represent the means ± SD of triplicate determinations from a typical 
experiment. Similar results were obtained in two separate experi-
ments. 
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its presence in the assay did not affect the AP enzymatic 
activity (results not shown). Interestingly, the amounts of 
AP were also found to be decreased in other stably transfected 
mammalian cell lines. In human carcinoma HT-29 cells and 
Madin Darby canine kidney (MDCK) cells expressing differ-
ent foreign proteins, cell-associated AP was reduced to 30-
70% of the respective control wild-type cells. 
3.2. Effects of G418 and other aminoglycoside antibiotics on 
COS-1 cells 
To further study the reduction of AP activity in COS-1 
cells, we treated wild-type COS-1 cells and «eo-cells with 
G418 and several other aminoglycoside antibiotics. We found 
that the cell-associated AP activity in wild-type COS-1 cells 
grown for 24 h in the presence of 750 ug/ml G418 was re-
duced to less than 50% of control untreated cells (Fig. 1A, 
bars a,b). A similarly reduced AP activity was also observed 
in «eo-cells grown for more than 4 months in the constant 
presence of 300 ug/ml G418 (Fig. 1A, bar c). A further reduc-
tion in AP activity was observed in these »eo-cells after in-
creasing the concentration of G418 in the medium from 300 
ug/ml, i.e. the typical concentration we used to culture neo-
resistant COS-1 cells, to 750 ug/ml (Fig. 1A, bar d). Together 
with the decrease in AP activity in wild-type COS-1 cells we 
found that the AP activity in the culture supernatant in-
creased (Fig. 1A, bars e,f), indicating that AP was released 
from the cells into the medium. 
In addition, all the other aminoglycosides tested also caused 
a reduction in AP activity when added to wild-type COS-1 
cells in culture. Gentamycin, a close structural analogue to 
G418, showed a similar AP reduction as G418, while neomy-
cin, kanamycin, and in particular streptomycin, were some-
what less effective in reducing cell-associated AP activity (Ta-
ble 1 ; the final concentrations of all antibiotics in the culture 
media were 750 ug/ml). 
As mentioned above, G418 (and other aminoglycoside anti-
biotics) has been proposed to inhibit protein biosynthesis in 
mammalian cells by binding to the 80S ribosomes [5,23]. In 
order to study if G418 reduced the amount of cell-associated 
AP in COS-1 cells by inhibition of protein biosynthesis, we 
measured the activities of two other enzymes, i.e. cytosolic 
LDH and membrane-bound Na+/K+-ATPase, in COS-1 cells. 
We found that the activities of both enzymes in wild-type 
COS-1 cells grown for 24 h in the presence of 750 ug/ml 
G418 were unchanged compared to control untreated cells 
(results not shown). Similarly, the LDH and Na+/K+-ATPase 
Table 1 
Reduction of AP activity in wild-type COS-1 cells in the presence of 
different aminoglycoside antibiotics 
Antibiotic added 
G418 (Geneticin) 
Gentamycin 
Neomycin 
Kanamycin 
Streptomycin 
AP activity (% reduction compared to 
wild-type cells) 
42-6P 
55/63b 
40/42b 
35/42b 
19/29b 
Confluent wild-type COS-1 cells were grown for 24 h in the presence 
of different aminoglycoside antibiotics (750 |xg/ml final concentration) 
and the activity of AP in the washed cell pellets was measured as 
described in Section 2. 
"Range of 13 independent experiments. 
bValues from two independent experiments. 
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Fig. 2. A: Concentration-dependent decrease of AP specific activity 
in G418-treated COS-1 cells. Confluent wild-type COS-1 cells were 
incubated for 24 h in the absence or presence of increasing concen-
trations of G418 (in mM), and the specific activity of AP in the 
washed cell pellets was determined. B: AP activity in rceo-cells cul-
tured for several passages in the absence of G418. iVeo-cells (bar a) 
were cultured for 26 weeks (26 passages; 1:10 dilution steps) in the 
absence of G418 and the specific activity of AP in the washed cell 
pellets was determined after 7, 12, and 26 passages (bars b, c, d, re-
spectively). Control «eo-cells were incubated in the presence of 300 
ag/ml G418 for 26 passages (bar e). The data represent the mean 
values ± SD of triplicate determinations from a single experiment. 
activities in «eo-cells were identical to wild-type COS-1 cells 
(results not shown). 
Together, these results show that G418 and other amino-
glycoside antibiotics cause a reduction in cell-associated AP 
activity in COS-1 cells. Since the G418-induced reduction in 
AP activity was not only observed in «eo-cells but also in 
wild-type COS-1 cells, it was not the result of the expression 
of the neomycin resistance gene product (i.e. a phosphotrans-
ferase) but of the presence of G418 in the culture medium. In 
addition, the reduced AP activity in G418-treated COS-1 cells 
was not due to a general effect of G418 on protein synthesis in 
COS-1 cells since other cell enzymes were not affected by the 
treatment. 
3.3. Time- and concentration-dependent effects of G418 on AP 
activity in wild-type COS-1 cells 
In order to further characterize the G418-induced decrease 
of cell-associated AP, wild-type COS-1 cells were cultured in 
the presence of G418 for 56 h and cells and culture media 
were assayed for AP activity. We found that the AP activity in 
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Fig. 3. A: Time-dependent release of AChE from human erythrocytes. Washed human erythrocytes were incubated for 24 h in the absence 
(open circles) or presence of 7.5 mg/ml G418 (closed circles). At indicated time points erythrocytes were pelleted by centrifugation and the 
AChE activity in the vesicle-containing supernatant was measured and expressed as the percentage of the total activity in the suspension before 
centrifugation. The values represent the means of triplicate determinations from a typical experiment. Similar results were obtained in two sepa-
rate experiments. When lower concentrations of G418 (750 |xg/ml to 3.25 mg/ml) were used, the onset of vesiculation was delayed and the ex-
tent of AChE release was decreased (results not shown). B: Protein composition of erythrocyte-derived vesicles. Human erythrocyte ghosts 
(lane 1) and vesicles released from erythrocytes after treatment with G418 for 24 h (lane 2) were analyzed by SDS-PAGE and staining of pro-
teins with Coomassie brilliant blue. Spectrin migrates as a doublet of non-identical subunits with apparent molecular masses of 260 and 246 
kDa. Note that AChE is not detectable by protein staining due to its low copy number in human erythrocytes. 
the cell pellets rapidly decreased after addition of G418 and 
remained constant over the entire period of the experiment 
(Fig. IB). The reduction in cell-associated AP activity was 
observed regardless of the time of G418 addition to the 
COS-1 cells and could not be reversed by a subsequent re-
Table 2 
Release of AChE from human erythrocytes in the presence of differ-
ent aminoglycoside antibiotics 
Antibiotic added 
G418 (Geneticin) 
Gentamycin 
Neomycin 
Kanamycin 
Streptomycin 
no antibiotic 
AChE activity (% 
the suspension) 
in supernatant 1 
11.8-16.3a 
14.8b 
13.lb 
14.8b 
1.8C 
1.2-2.0" 
of total activity in 
in supernatant 2 
0.6C 
1.9b 
0.7b 
1.8b 
0.3C 
0.3C 
Human erythrocytes were incubated at 37°C in the absence or pres-
ence of different aminoglycoside antibiotics (all at a final concentra-
tion of 7.5 mg/ml). After 24 h of incubation, the suspensions were 
pelleted by low-speed centrifugation and the AChE activity in the cell-
free supernatant was measured before (supernatant 1) and after 
(supernatant 2) high-speed centrifugation to pellet the erythrocyte-
derived vesicles. The total AChE activity in the suspension stayed 
constant during the incubation period and was not affected by the 
presence of the aminoglycoside antibiotics. 
aRange of seven independent experiments. 
b Single determinations. 
cMean from two independent experiments. 
mo val of G418 from the culture medium (results not shown; 
see also below). Longer incubation times could not be applied 
since the wild-type COS-1 cells were not viable after 3 days in 
culture in the presence of G418. 
In several mammalian cell types, AP has been shown to be 
anchored to the plasma membrane via covalently attached 
GPL Accordingly, we found that more than 70% of AP in 
wild-type COS-1 cells was susceptible to PI-PLC treatment 
indicating that the endogenous AP in COS-1 cells is mem-
brane-anchored via GPL In addition, we noticed that the 
AP in the culture supernatant from G418-treated COS-1 cells 
quantitatively partitioned into the detergent phase after phase 
partitioning in Triton X-114. In contrast, after treatment of 
the supernatant with bacterial PI-PLC, more than 55% of the 
AP activity was recovered in the aqueous phase. These results 
demonstrate that the AP released from COS-1 cells into the 
supernatant contained a GPI anchor. This observation was 
important since it had previously been reported that G418 
can activate PI-PLCs capable of cleaving protein GPI anchors 
[24]. However, we were unable to detect such an activity in 
G418-treated COS-1 cells using either endogenous AP or exo-
genously added GPI-anchored AChE or VSG as substrates 
(results not shown). Together these results exclude the possi-
bility that the appearance of the AP in the culture supernatant 
resulted from a possible (transient) activation of a GPI-hydro-
lyzing phospholipase in COS-1 cells. 
Usually, stably transfected COS-1 cells are maintained in 
culture in the presence of 300-500 (ig/ml G418. In order to 
study the effects of different concentrations of G418 on cell-
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associated AP activity, we incubated wild-type COS-1 cells in 
the presence of 7.5 ng-7.5 mg/ml (equaling 10 nM-10 mM) 
G418 for 24 h. Our results showed that the reduction in cell-
associated AP activity strictly correlated with the increase in 
the concentration of G418 in the culture medium (Fig. 2A). 
At a very low concentration of 100 nM G418, the AP activity 
in COS-1 cells was reduced by ~ 1 0 % whereas a ~ 5 0 % re-
duction was observed in the presence of 10 mM G418 in the 
culture medium. 
In order to study if the G418-induced reduction in cell-
associated AP activity was reversible, we cultured «eo-cells 
in the absence of G418 over a period of 26 weeks (Fig. 2B). 
As mentioned above, «eo-cells grown in the presence of 300 
Hg/ml G418 showed a reduction in AP activity of more than 
50% compared to wild-type COS-1 cells (Fig. 2B, bar a). 
When these cells were subsequently cultured in the absence 
of G418, the cell-associated AP activity slowly increased to 
~ 70% of control wild-type cells after 7 passages (Fig. 2B, bar 
b). An almost complete recovery of AP activity in «eo-cells to 
92% and 95% of control wild-type COS-1 cells was observed 
after 12 and 26 passages, respectively, in the absence of G418 
(Fig. 2B, bars c,d). In contrast, in control «eo-cells cultured 
for the same period of time in the presence of G418, the AP 
activity remained unchanged at less than 50% of control wild-
type cells (Fig. 2B, bar e). If G418 was added back to «eo-cells 
grown for 12 passages in the absence of the antibiotic, the AP 
activity immediately decreased again to less than 50% of con-
trol wild-type cells (results not shown). Thus, in order to re-
store the cell-associated AP activity in «eo-cells to wild-type 
COS-1 cell levels, the cells need to be cultured for at least 12 
passages in the absence of G418. 
Together these findings demonstrate that the addition of 
G418 to COS-1 cells in culture results in a rapid release of 
cell-associated AP into the culture supernatant. Interestingly, 
we found that the GPI-anchored AP in the supernatant could 
be quantitatively pelleted by high-speed centrifugation (results 
not shown), suggesting that it may be associated with mem-
branous material that was released from COS-1 cells together 
with the AP. Unfortunately, the limited amount of material 
obtained from the supernatants did not allow a detailed anal-
ysis of its composition. 
3.4. Effect of different aminoglycoside antibiotics on human 
erythrocytes 
It has been reported that human erythrocytes can be in-
duced to release membrane vesicles enriched in GPI-anchored 
proteins. Depletion of intracellular ATP stores [25], loading 
with calcium [26], and incubation in the presence of dimyris-
toylphosphatidylcholine [21] all lead to dramatic shape 
changes of human erythrocytes followed by a release of 
vesicles highly enriched in the GPI-anchored proteins AChE 
[21,25,26], decay accelerating factor [27], and membrane in-
hibitor of reactive lysis [28]. The extent of vesiculation could 
be modulated by a series of amphiphilic compounds that in-
tercalate into the plasma membrane [21]. Since the vesicula-
tion process of human erythrocytes has been relatively well 
characterized, we decided to use human erythrocytes as a 
model system to study if the G418-induced release of GPI-
anchored AP from COS-1 cells may involve a vesiculation 
event. 
Human erythrocytes release vesicles after prolonged incu-
bation in nutrient-poor buffer leading to ATP-depletion of the 
cells. In contrast, in the presence of glucose, inosine, and 
adenine, vesiculation is virtually inhibited [25]. The released 
vesicles are enriched in GPI-anchored AChE and, in addition, 
contain several membrane-bound proteins but are virtually 
devoid of the major skeletal protein, spectrin [25]. Interest-
ingly, we found that when human erythrocytes were incubated 
in the presence of G418 under conditions to maintain intra-
cellular ATP levels, they released AChE-containing vesicles 
into the cell-free supernatant (Fig. 3A). After 24 h of incuba-
tion at 37°C, 12-16% of total AChE activity in the suspension 
was recovered in the vesicle fraction whereas less than 2% of 
AChE activity was released from erythrocytes incubated in the 
absence of G418. The release of AChE from human erythro-
cytes was also observed after the addition of other amino-
glycoside antibiotics to the cells (Table 2). While the extent 
of AChE release in the presence of gentamycin, neomycin, 
and kanamycin was similar to that observed in the presence 
of G418, little release of AChE was observed after the addi-
tion of streptomycin to human erythrocytes (Table 2). The 
isolated G418-induced vesicles showed the typical protein pat-
tern of erythrocyte-derived vesicles, notably the complete ab-
sence of the major skeletal protein, spectrin (Fig. 3B; see also 
ref [25]). 
In summary, we found that the addition of G418 and other 
aminoglycoside antibiotics to COS-1 cells in culture resulted 
in a reduction of cell-associated endogenous GPI-anchored 
AP. In wild-type COS-1 cells this decrease could not be re-
versed by short-term removal of G418 from the incubation 
medium. In contrast, in «eo-cells the AP activity could be 
restored to normal, i.e. wild-type COS-1 cell levels after at 
least 12 continuous cell passages in the absence of G418. 
The AP present in the culture supernatant was shown to con-
tain a GPI anchor and could be pelleted by centrifugation 
suggesting that it was associated with membranous material 
released from COS-1 cells. Since the aminoglycoside antibiot-
ics were found to induce a release of vesicles enriched in GPI-
anchored AChE from human erythrocytes, we speculate that 
the G418-induced release of GPI-anchored AP from COS-1 
cells may also occur via vesiculation. Furthermore, since it has 
been shown that erythrocyte-derived vesicles are not only en-
riched in AChE [21,25,26] but also other GPI-anchored pro-
teins [27,28], it is possible that additional GPI-anchored pro-
teins besides AP are released from COS-1 cells after treatment 
with the aminoglycoside antibiotics. Unfortunately, the activ-
ity of 5'-nucleotidase which represents another GPI-anchored 
cell surface enzyme often studied in mammalian cells, was 
below the limit of detection in wild-type COS-1 cells and 
could not be used as an additional marker for the release of 
GPI-anchored proteins (results not shown). At present, the 
mechanism of how the aminoglycoside antibiotics induce ves-
iculation in mammalian cells is completely unclear. 
Resistance to aminoglycoside antibiotics forms the basis of 
a widely used dominant selectable marker system in animal 
[29,30] and plant [31] cells. Over the past years, a number of 
G418-resistant cell lines have been used to study the expres-
sion and sorting of GPI-anchored proteins [32-34]. Although 
our present findings may not have direct implications for these 
reports, they at least strongly suggest that the results from 
studies involving mammalian cells cultured in the presence 
of G418 (or other aminoglycoside antibiotics) need to be in-
terpreted with great caution, in particular if they relate to 
GPI-anchored proteins. The possibility that the presence of 
338 M. Küng et al.lFEBS Letters 409 (1997) 333-338 
G418 causes the cells to release vesicles enriched in GPI-an-
chored proteins has to be considered and should be accounted 
for by using G418-resistant cells cultured for at least 12 pas-
sages in the absence of any antibiotic. Alternatively, the re-
sults from G418-resistant cells expressing a given protein to be 
studied should be compared with mock transfected, i.e. G418-
resistant cells, and not with wild-type cells as it is usually 
done. Since a G418-induced reduction in cell-associated A P 
was not only found in COS-1 cells but also in HT-29 and 
M D C K cells, our findings may be applicable to cultured 
(mammalian) cells in general. 
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